Cargando…
Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Sodium glucose co-transporter 2 inhibitors (SGLT2i) have been associated with favourable outcomes in patients with heart failure. Studies also indicate a reduced risk of atrial fibrillation (AF). PURPOSE: We performed an explorator...
Autores principales: | Fawzy, A M, Bisson, A, Fauchier, L, Lip, G Y H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206686/ http://dx.doi.org/10.1093/europace/euad122.033 |
Ejemplares similares
-
Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant
por: Lee, S R, et al.
Publicado: (2023) -
Left atrial strain significance in prediction of early atrial fibrillation recurrence after cardioversion and ablation
por: Sabanovic-Bajramovic, N, et al.
Publicado: (2023) -
The role of education level in the mortality of hospitalized patients with atrial fibrillation
por: Sztaniszlav, A, et al.
Publicado: (2023) -
Predictors and outcomes of late atrial fibrillation following coronary artery bypass grafting
por: Jameie, M, et al.
Publicado: (2023) -
Disease awareness and knowledge of stroke- and atrial fibrillation risk factors in cardiovascular patients
por: Engler, D, et al.
Publicado: (2023)